期刊文献+

PLGA微粒/纳米粒基因载体的研究进展 被引量:12

Advance in the study of poly(lactide-co-glycolide) nano/microparticles as gene vector
原文传递
导出
摘要 生物可降解聚合物乳酸-羟基乙酸共聚物(PLGA)微米粒/纳米粒是一种新型的非病毒基因载体,由于其具有安全、无免疫原性、制备容易和装载容量大等优点而引起越来越多的关注和研究,特别是在质粒DNA(plasmid DNA,pDNA)传递方面具有巨大的研究空间和潜在应用价值。本文依据PLGA微米粒/纳米粒在基因载体中的研究现状,重点综述了载体的制备工艺和表面修饰方法及其在基因治疗和基因疫苗传递等方面的应用研究进展。 Biodegradable nano/microparticles of poly(D, L-lactide-co-glycolide) (PLGA) is a novel non-viral gene vector, which has many advantages, such as safety, non-immunogenicity, easy of large-scale preparation and well load-capability. Therefore, more and more attentions and researches have been paid on its application. Especially, PLGA has shown enormous potential application value and space in the field of plasmid DNA (pDNA) delivery system. On the basis of the current situation of PLGA nano/microparticles for pDNA delivery, this paper focused on summarizing the current preparation approaches and surface modified methods of PLGA particle, furthermore showing its application in gene therapy and genetic vaccine delivery. These showed that PLGA nano/microparticles have extensive prospect in the development of controlled gene delivery system.
出处 《药学学报》 CAS CSCD 北大核心 2010年第11期1346-1353,共8页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(30771921)
关键词 乳酸-羟基乙酸共聚物 基因传递 基因治疗 表面修饰 poly(lactide-co-glycolide) gene delivery system gene therapy surface modification
  • 相关文献

参考文献48

  • 1Gary D J, Puri N, Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery [J]. J Control Release, 2007, 121: 64-73.
  • 2Lee YK, So IS, Lee SC, et al. Suppression of distant pulmonary metastasis of MDA2-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TMP-2 gene transfer [J]. J Gene Med, 2005, 7: 145-157.
  • 3Kenneth R, Rogulshki MS, Wing DL, et al. Double suicide gene therapy augments the antitumor activity of a replication- competent lytic adenovirus through enhanced cytotoxicity and radiosensitization [J]. Hum Gene Ther, 2000, 1 : 67-76.
  • 4Wang Z, Zhu T, Qiao C, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart [J]. Nat Biotechnol, 2005, 23: 321-328.
  • 5Zimmermann TS, Lee AC, Akinc A, et al. RNAi-mediated gene silencing in non-human primates [J]. Nature, 2006, 441: 111-114.
  • 6Herweijer H, Wolff JA. Progress and prospects: naked DNA genetransfer and therapy [J]. Gene Ther, 2003, 10: 453-458.
  • 7Mundargi RC, Babu VR, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives [J]. J Control Release, 2008, 125: 193-209.
  • 8Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue [J]. Adv Drug Deliv Rev, 2003, 55: 329-347.
  • 9Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression [J]. Pharm Res, 2004, 21: 354-364.
  • 10Luten J, van Nostrum CF, De Smedt SC, et al. Biodegradable polymers as non-viral carriers for plasmid DNA delivery [J]. J Control Release, 2008, 126:97-110.

同被引文献139

引证文献12

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部